MY147409A
Nucleoside phosphoramidate prodrugs
Abstract
DISCLOSED HEREIN ARE PHOSPHORAMIDATE PRODRUGS OF NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS IN MAMMALS, WHICH IS A COMPOUND, ITS STEREOISOMER, SALT (ACID OR BASIC ADDITION SALT), HYDRATE, SOLVATE, OR CRYSTALLINE FORM THEREOF, REPRESENTED BY THE FOLLOWING STRUCTURE: ALSO DISCLOSED ARE METHODS OF TREATMENT, USES, AND PROCESSES FOR PREPARING EACH OF WHICH UTILIZE THE COMPOUND REPRESENTED BY FORMULA (I).
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| US3798209A | Cites | United States of America |
| US3852267A | Cites | United States of America |
| US5372808A | Cites | United States of America |
154 members in 37 offices
Priority claims15
| Document | Office | Kind | Date |
|---|---|---|---|
| 60909315 | United States of America | – | |
| 90931507 | United States of America | P | |
| 90931507 | United States of America | P | |
| 60982309 | United States of America | – | |
| 98230907 | United States of America | P | |
| 98230907 | United States of America | P | |
| 12053015 | United States of America | – | |
| 5301508 | United States of America | A | |
| 5301508 | United States of America | A | |
| 12053015 | – | – | – |
| 60909315 | – | – | – |
| 60982309 | – | – | – |
| US20070909315P | – | – | – |
| US20070982309P | – | – | – |
| US20080053015 | – | – | – |
Members154
| Document | Office | Kind | |
|---|---|---|---|
| AU2008232827A1 | Australia | A1 | |
| CA2682230A1 | Canada | A1 | |
| WO2008121634A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CL2008000902A1 | Chile | A1 | |
| TW200904453A | Taiwan Province of China | A | |
| AR066898A1 | Argentina | A1 | |
| MX2009010401A | Mexico | A | |
| US2010016251A1 | United States of America | A1 | |
| KR20100016041A | Republic of Korea | A | |
| WO2008121634A3 | World Intellectual Property Organization (WIPO) | A3 | |
| IL201239A0 | Israel | A0 | |
| IL201239D0 | Israel | D0 | |
| EP2203462A2 | European Patent Office (EPO) | A2 | |
| JP2010532747A | Japan | A | |
| CN101918425A | China | A | |
| CO6260023A2 | Colombia | A2 | |
| RU2009139968A | Russian Federation | A | |
| US7964580B2 | United States of America | B2 | |
| US2011257122A1 | United States of America | A1 | |
| IL217228A0 | Israel | A0 | |
| IL217228D0 | Israel | D0 | |
| TWI357332B | Taiwan Province of China | B | |
| KR20120034801A | Republic of Korea | A | |
| SG179445A1 | Singapore | A1 | |
| NZ579880A | New Zealand | A | |
| JP2012121903A | Japan | A | |
| AU2008232827B2 | Australia | B2 | |
| AU2012241173A1 | Australia | A1 | |
| MY147409AThis record | Malaysia | A | |
| US8334270B2 | United States of America | B2 | |
| IL222810A0 | Israel | A0 | |
| IL222810D0 | Israel | D0 | |
| US2013029929A1 | United States of America | A1 | |
| IL201239A | Israel | A | |
| RU2478104C2 | Russian Federation | C2 | |
| ZA201200310B | South Africa | B | |
| ZA200906647B | South Africa | B | |
| IL217228A | Israel | A | |
| NZ599206A | New Zealand | A | |
| JP5318085B2 | Japan | B2 | |
| US8580765B2 | United States of America | B2 | |
| US2014045783A1 | United States of America | A1 | |
| CA2682230C | Canada | C | |
| EP2203462B1 | European Patent Office (EPO) | B1 | |
| US8735372B2 | United States of America | B2 | |
| SG2014011704A | Singapore | A | |
| RU2012152811A | Russian Federation | A | |
| JP5539419B2 | Japan | B2 | |
| US2014187511A1 | United States of America | A1 | |
| DK2203462T3 | Denmark | T3 | |
| KR101432860B1 | Republic of Korea | B1 | |
| PT2203462E | Portugal | E | |
| ES2492470T3 | Spain | T3 | |
| AU2014215983A1 | Australia | A1 | |
| AU2012241173B2 | Australia | B2 | |
| US2014288020A1 | United States of America | A1 | |
| SI2203462T1 | Slovenia | T1 | |
| SI2203462T1 | Slovenia | T1 | |
| HRP20140667T1 | Croatia | T1 | |
| AU2014233579A1 | Australia | A1 | |
| JP2014196305A | Japan | A | |
| EP2792680A1 | European Patent Office (EPO) | A1 | |
| US2014315852A1 | United States of America | A1 | |
| EP2801580A1 | European Patent Office (EPO) | A1 | |
| FIC20140055I1 | Finland | I1 | |
| NO2014029I2 | Norway | I2 | |
| NO2014029I1 | Norway | I1 | |
| US8906880B2 | United States of America | B2 | |
| FR14C0082I1 | France | I1 | |
| EP2824109A1 | European Patent Office (EPO) | A1 | |
| EP2826784A1 | European Patent Office (EPO) | A1 | |
| KR20150008929A | Republic of Korea | A | |
| PL2203462T3 | Poland | T3 | |
| JP2015024998A | Japan | A | |
| US8957046B2 | United States of America | B2 | |
| CN104402955A | China | A | |
| AU2008232827C1 | Australia | C1 | |
| BRPI0809654A2 | Brazil | A2 | |
| KR101525293B1 | Republic of Korea | B1 | |
| KR101527701B1 | Republic of Korea | B1 | |
| US9085573B2 | United States of America | B2 | |
| US2015231166A1 | United States of America | A1 | |
| JP5774749B2 | Japan | B2 | |
| EP2933260A1 | European Patent Office (EPO) | A1 | |
| PH12014502771A1 | Philippines | A1 | |
| BRPI0823519A2 | Brazil | A2 | |
| FR14C0082I2 | France | I2 | |
| LU92600I2 | Luxembourg | I2 | |
| NL300704I1 | Netherlands (Kingdom of the) | I1 | |
| NL300704I2 | Netherlands (Kingdom of the) | I2 | |
| HK1206033A | Hong Kong, China | A | |
| HK1206033A1 | Hong Kong, China | A1 | |
| HK1206034A | Hong Kong, China | A | |
| HK1206034A1 | Hong Kong, China | A1 | |
| JP2016023187A | Japan | A | |
| AU2014233579B2 | Australia | B2 | |
| AU2016213882A1 | Australia | A1 | |
| AU2016231535A1 | Australia | A1 | |
| CY1115488T1 | Cyprus | T1 | |
| US9585906B2 | United States of America | B2 |
Showing 100 of 154
Numbers
- Publication
- MY-147409-A
- Publication, DOCDB
- 147409
- Publication, EPODOC
- MY147409
- Application
- 200904079
- Application, DOCDB
- PI20094079
- Application, EPODOC
- MY2009PI04079
Titles
- English
- NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS
Classification
- CPC, 22
- C07H19/10
- A61K31/7064
- A61K31/7072
- C07H19/16
- A61K31/706
- A61K31/7076
- A61K31/7068
- C07D417/14
- A61P31/00
- A61P31/12
- A61P31/14
- A61P31/16
- A61P31/18
- A61P31/20
- A61P43/00
- Y02A50/30
- C07H19/06
- C07H19/20
- C07H19/04
- A61K45/06
- C07H17/02
- C07H19/073